Label: NAUZENE- sodium citrate tablet, chewable
-
NDC Code(s):
52389-242-10,
52389-242-40,
52389-242-42,
52389-242-50, view more52389-242-56
- Packager: Alva-Amco Pharmacal Companies, Inc.
- Category: HUMAN OTC DRUG LABEL
Drug Label Information
Updated May 8, 2024
If you are a healthcare professional or from the pharmaceutical industry please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (in each chewable tablet)
- Purpose
- Uses
- Warnings
- DO NOT USE
- Ask a doctor before use if you
- ASK DOCTOR/PHARMACIST
- WHEN USING
- STOP USE
- PREGNANCY OR BREAST FEEDING
- KEEP OUT OF REACH OF CHILDREN
-
Directions
- Adults: 2 - 4 tablets.
- Children: Consult a doctor for appropriate dosage.
- Chew tablets completely.
- Dosage may be repeated after 15 minutes, not to exceed 24 tablets in a 24-hour period unless advised by a doctor.
- Read all package directions and warning before use and use only as directed.
- Nauzene Chewables are intended for use by normally healthy persons only.
- Persons under 18 years of age should use only as directed by a doctor.
-
Other information
- Sodium content: 60 mg/tablet
- Store at room temperature.
- **Contents sealed: Each round pink Nauzene chewable tablet bears the identifying mark "ALVA" and is sealed in a clear plastic blister with a foil backing. Do not use if seal appears broken or if product contents do not match product description. Slight red speckling may occur over time.
- Note: Nauzene is not intended as a substitute for a balanced nutritional diet or as an electrolyte replenishment.
- You may report serious side effects to the phone number provided under Questions? below.
- Inactive ingredients
- QUESTIONS
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
NAUZENE
sodium citrate tablet, chewableProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:52389-242 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TRISODIUM CITRATE DIHYDRATE (UNII: B22547B95K) (ANHYDROUS CITRIC ACID - UNII:XF417D3PSL) ANHYDROUS CITRIC ACID 230 mg Inactive Ingredients Ingredient Name Strength ASPARTAME (UNII: Z0H242BBR1) FD&C RED NO. 40 (UNII: WZB9127XOA) MAGNESIUM STEARATE (UNII: 70097M6I30) MALTODEXTRIN (UNII: 7CVR7L4A2D) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) STEARIC ACID (UNII: 4ELV7Z65AP) DEXTROSE (UNII: IY9XDZ35W2) FRUCTOSE (UNII: 6YSS42VSEV) MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE) (UNII: 461P5CJN6T) HYPROMELLOSES (UNII: 3NXW29V3WO) POVIDONE K30 (UNII: U725QWY32X) SUCROSE (UNII: C151H8M554) CHERRY (UNII: BUC5I9595W) Product Characteristics Color pink Score no score Shape ROUND Size 16mm Flavor CHERRY (Wild Cherry Flavor) Imprint Code ALVA Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:52389-242-40 4 in 1 CARTON 07/08/2000 1 10 in 1 BLISTER PACK; Type 0: Not a Combination Product 2 NDC:52389-242-42 3 in 1 CARTON 07/06/2017 2 14 in 1 BLISTER PACK; Type 0: Not a Combination Product 3 NDC:52389-242-50 5 in 1 CARTON 10/01/2006 3 10 in 1 BLISTER PACK; Type 0: Not a Combination Product 4 NDC:52389-242-10 1 in 1 CARTON 07/15/2016 4 10 in 1 BLISTER PACK; Type 0: Not a Combination Product 5 NDC:52389-242-56 4 in 1 CARTON 11/16/2019 5 14 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M001 07/08/2000 Labeler - Alva-Amco Pharmacal Companies, Inc. (042074856)